TipRanks
Go Ultimate55% OFF

Compare Alterity Therapeutics (PBN) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:PBNAlterity TherapeuticsEUR 0.15EUR 38.09M-2.40-70.80%Moderate BuyDE:PBN
AU:ACWActinogen Medical AUD 0.04AUD 162.72M-8.7523.53%Moderate BuyDE:PBN vs AU:ACW
AU:CYPCynata Therapeutics LimitedAUD 0.01AUD 4.02M-0.31-94.98%―DE:PBN vs AU:CYP
AU:ENPTryptamine TherapeuticsAUD 0.03AUD 50.66M-13.48-16.22%―DE:PBN vs AU:ENP
AU:1AILiving Cell TechnologiesAUD 0.01AUD 20.28M-5.710.00%―DE:PBN vs AU:1AI
AU:NEUNeuren Pharmaceuticals LimitedAUD 20.36AUD 2.58B128.62-7.20%Strong BuyDE:PBN vs AU:NEU

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:PBNAlterity Therapeutics0.15-0.05-27.00%
AU:ACWActinogen Medical 0.040.0116.67%
AU:CYPCynata Therapeutics Limited0.01-0.22-94.78%
AU:ENPTryptamine Therapeutics0.03-0.01-18.42%
AU:1AILiving Cell Technologies0.010.000.00%
AU:NEUNeuren Pharmaceuticals Limited20.36-0.44-2.10%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts